| Design, Synthesis, and Biological Evaluation of the First Selective Nonpeptide AT2 Receptor Agonist Y Wan, C Wallinder, B Plouffe, H Beaudry, AK Mahalingam, X Wu, ... Journal of medicinal chemistry 47 (24), 5995-6008, 2004 | 407 | 2004 |
| Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain AJ Parent, N Beaudet, H Beaudry, J Bergeron, P Bérubé, G Drolet, ... Behavioural brain research 229 (1), 160-167, 2012 | 158 | 2012 |
| Activation of spinal μ-and δ-opioid receptors potently inhibits substance P release induced by peripheral noxious stimuli H Beaudry, D Dubois, L Gendron Journal of Neuroscience 31 (37), 13068-13077, 2011 | 92 | 2011 |
| Optogenetic silencing of Nav1. 8-positive afferents alleviates inflammatory and neuropathic pain I Daou, H Beaudry, AR Ase, JS Wieskopf, A Ribeiro-da-Silva, JS Mogil, ... Eneuro 3 (1), 2016 | 85 | 2016 |
| Recent advances on the δ opioid receptor: from trafficking to function L Gendron, N Mittal, H Beaudry, W Walwyn British journal of pharmacology 172 (2), 403-419, 2015 | 84 | 2015 |
| Distinct behavioral responses evoked by selective optogenetic stimulation of the major TRPV1+ and MrgD+ subsets of C-fibers H Beaudry, I Daou, AR Ase, A Ribeiro-da-Silva, P Séguéla Pain 158 (12), 2329-2339, 2017 | 74 | 2017 |
| Differential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents H Beaudry, A Proteau-Gagne, S Li, Y Dory, C Chavkin, L Gendron Neuroscience 161 (2), 381-391, 2009 | 62 | 2009 |
| New Selective AT2 Receptor Ligands Encompassing a γ-Turn Mimetic Replacing the Amino Acid Residues 4−5 of Angiotensin II Act as Agonists U Rosenström, C Sköld, B Plouffe, H Beaudry, G Lindeberg, M Botros, ... Journal of medicinal chemistry 48 (12), 4009-4024, 2005 | 58 | 2005 |
| Role of Tyrosine Kinase Receptors in Angiotensin II AT2 Receptor Signaling: Involvement in Neurite Outgrowth and in p42/p44mapk Activation in NG108-15 Cells B Plouffe, MO Guimond, H Beaudry, N Gallo-Payet Endocrinology 147 (10), 4646-4654, 2006 | 43 | 2006 |
| Selective angiotensin II AT2 receptor agonists: Benzamide structure–activity relationships C Wallinder, M Botros, U Rosenström, MO Guimond, H Beaudry, F Nyberg, ... Bioorganic & medicinal chemistry 16 (14), 6841-6849, 2008 | 41 | 2008 |
| Short pseudopeptides containing turn scaffolds with high AT2 receptor affinity J Georgsson, U Rosenström, C Wallinder, H Beaudry, B Plouffe, ... Bioorganic & medicinal chemistry 14 (17), 5963-5972, 2006 | 31 | 2006 |
| Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory … H Beaudry, L Gendron, JA Morón European Journal of Neuroscience 41 (7), 901-907, 2015 | 30 | 2015 |
| Pain after discontinuation of morphine treatment is associated with synaptic increase of GluA4-containing AMPAR in the dorsal horn of the spinal cord D Cabanero, A Baker, S Zhou, GL Hargett, T Irie, Y Xia, H Beaudry, ... Neuropsychopharmacology 38 (8), 1472-1484, 2013 | 30 | 2013 |
| Involvement of Protein Kinase Cα (PKCα) in the Early Action of Angiotensin II Type 2 (AT2) Effects on Neurite Outgrowth in NG108–15 Cells: AT2-Receptor Inhibits PKCα and p21 … H Beaudry, L Gendron, MO Guimond, MD Payet, N Gallo-Payet Endocrinology 147 (9), 4263-4272, 2006 | 24 | 2006 |
| Altered morphine-induced analgesia in neurotensin type 1 receptor null mice G Roussy, H Beaudry, M Lafrance, K Belleville, N Beaudet, K Wada, ... Neuroscience 170 (4), 1286-1294, 2010 | 22 | 2010 |
| Regulation of μ and δ opioid receptor functions: involvement of cyclin‐dependent kinase 5 H Beaudry, AA Mercier‐Blais, C Delaygue, C Lavoie, JL Parent, ... British journal of pharmacology 172 (10), 2573-2587, 2015 | 21 | 2015 |
| Will optogenetics be used to treat chronic pain patients? H Beaudry, I Daou, A Ribeiro-da-Silva, P Séguéla Pain management 7 (4), 269-278, 2017 | 7 | 2017 |
| Optogénétique et douleur chronique: une stratégie applicable chez l’humain? H Beaudry, I Daou, A Ribeiro-da-Silva, P Séguéla Douleur et analgésie 4 (29), 232-240, 2016 | 2 | 2016 |
| Can we use optogenetics to treat chronic pain? H Beaudry, I Daou, A Ribeiro-da-Silva, P Séguéla Douleur et analgésie 29, 232-240, 2016 | 1 | 2016 |
| Rôle et régulation du récepteur opioidérgique delta dans le traitement de la douleur. H Beaudry Library and Archives Canada= Bibliothèque et Archives Canada, Ottawa, 2013 | | 2013 |
